Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This trial intends to evaluate myocardial Fibrosis progression in Duchenne and Becker
Muscular Dystrophy, as well the influence of ACE inhibitors in fibrosis progression.
Additionally, this study aims to determine genetic predictors of cardiac involvement in these
dystrophies.
Phase:
Phase 3
Details
Lead Sponsor:
InCor Heart Institute
Collaborators:
Federal University of Minas Gerais University of Sao Paulo